How have OBD shares performed in 2024?

Oxford BioDynamics' stock was trading at GBX 28 at the start of the year. Since then, OBD shares have decreased by 68.2% and is now trading at GBX 8.90. View the best growth stocks for 2024 here .

How were Oxford BioDynamics' earnings last quarter?

Oxford BioDynamics Plc (LON:OBD) posted its earnings results on Tuesday, June, 16th. The biotechnology company reported ($2.20) EPS for the quarter.

What other stocks do shareholders of Oxford BioDynamics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oxford BioDynamics investors own include Oxford Biomedica (OXB) , Frontline (FRO) , Fate Therapeutics (FATE) , Cargojet (CJT) , China Unicom (Hong Kong) (CHU) , Casey's General Stores (CASY) , Buckle (BKE) , Biffa (BIFF) , AXT (AXTI) and Grupo Aval Acciones y Valores (AVAL) .

How do I buy shares of Oxford BioDynamics?

Shares of OBD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:OBD

Oxford BioDynamics (OBD) Share Price, News & Analysis

→ Forget Nvidia, buy this A.I. Stock Now (From InvestorPlace) (Ad)

Free OBD Stock Alerts

GBX 8.90

+0.05 (+0.56%)

(As of 04/17/2024 ET)

Compare

Today's Range: 8.72
▼
9
50-Day Range: 8.58
▼
15
52-Week Range: 8.38
▼
52

Volume: 345,485 shs
Average Volume: 814,678 shs
Market Capitalization: £18.00 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Competitors Headlines Insider Trades

Get Oxford BioDynamics alerts:

Ad InvestorPlace

Forget Nvidia, buy this A.I. Stock Now

Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.

Click here to see the details.

About Oxford BioDynamics Stock (LON:OBD)

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.

OBD Stock Price History

30 days | 90 days | 365 days | Advanced Chart

OBD Stock News Headlines

March 14, 2024 | msn.com

Where To Dine In Oxford For A Special Occasion

March 13, 2024 | uk.investing.com

Oxford Biodynamics PLC (OBD)

April 17, 2024 | InvestorPlace (Ad)

Forget Nvidia, buy this A.I. Stock Now

December 10, 2023 | msn.com

Oxford researchers develop early detection test for Parkinson's

November 3, 2023 | morningstar.com

Oxford BioDynamics PLC OBD

October 18, 2023 | finance.yahoo.com

Bupa UK to cover EpiSwitch® CiRT for customers with cancer

September 26, 2023 | msn.com

MARKET REPORT: Shares in prostate test firm more than double

September 4, 2023 | finance.yahoo.com

Several Insiders Invested In Oxford BioDynamics Flagging Positive News

April 17, 2024 | InvestorPlace (Ad)

Forget Nvidia, buy this A.I. Stock Now

August 1, 2023 | lse.co.uk

Oxford BioDynamics proposes GBP7 million fundraise for EpiSwitch plans

July 18, 2023 | uk.finance.yahoo.com

OBD.L - Oxford BioDynamics Plc

May 30, 2023 | marketwatch.com

Oxford BioDynamics Shares Fall on Wider 1H Loss, Need for More Cash

May 2, 2023 | marketwatch.com

Oxford BioDynamics Receives $963,000 Award for Adverse Response Oncology Test

February 10, 2023 | msn.com

This blood test can detect prostate cancer with 94 percent accuracy

February 8, 2023 | msn.com

Scientists create ‘impressive’ new blood test for prostate cancer that is 94% accurate

February 7, 2023 | msn.com

New blood test for prostate cancer is 94% accurate, researchers say

February 2, 2023 | finance.yahoo.com

The Non-Executive Director of Oxford BioDynamics Plc (LON:OBD), Stephen Diggle, Just Bought A Few More Shares

January 29, 2023 | finance.yahoo.com

Oxford BioDynamics Full Year 2022 Earnings: UK£0.067 loss per share (vs UK£0.072 loss in FY 2021)

December 19, 2022 | finance.yahoo.com

Oxford BioDynamics in San Francisco for the 41st Annual J.P. Morgan Healthcare Conference

December 16, 2022 | finance.yahoo.com

Massachusetts General Hospital Reports Results of Interim Analysis from REFINE-ALS Biomarker Trial by Mitsubishi Tanabe Pharma USA, Utilizing Oxford Biodynamics’ EpiSwitch® Platform for Prognostic Stratification of Fast Progression ALS

October 8, 2022 | fool.co.uk

Oxford BioDynamics

October 8, 2022 | finance.yahoo.com

Oxford BioDynamics (LON:OBD) Will Have To Spend Its Cash Wisely

October 7, 2022 | marketwatch.com

Oxford BioDynamics to Raise Up to GBP12 Mln to Boost Cancer Test Commercialization

June 28, 2022 | lse.co.uk

Oxford BioDynamics shares drop as it might need funding by early 2023

June 21, 2022 | barrons.com

Oxford BioDynamics's Checkpoint Inhibitor Response Test (EpiSwitch(R) CiRT) Now Available in the UK

March 11, 2022 | finance.yahoo.com

Oxford BioDynamics Plc (OBD.L)

November 22, 2021 | finance.yahoo.com

Is Oxford BioDynamics (LON:OBD) In A Good Position To Deliver On Growth Plans?

See More Headlines

Receive OBD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford BioDynamics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 6/16/2020
Today: 4/17/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: LON:OBD
CUSIP: N/A
CIK: N/A
Web: www.oxfordbiodynamics.com
Phone: +44-1865-518910
Fax: N/A
Employees: 45
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX (0.07)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-10,830,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -250.52%
Return on Assets: -46.27%

Debt

Debt-to-Equity Ratio: 106.34
Current Ratio: 1.79
Quick Ratio: 2.80

Sales & Book Value

Annual Sales: £176,000.00
Price / Sales: 102.30
Cash Flow: GBX 2.24 per share
Price / Cash Flow: 3.98
Book Value: GBX 3 per share
Price / Book: 2.97

Miscellaneous

Outstanding Shares: 202,300,000
Free Float: N/A
Market Cap: £18.00 million
Optionable: Not Optionable
Beta: 0.50

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

Dr. Jon Anthony Joseph Burrows B.Sc. (Age 62)
M.Sc., Ph.D., CEO & Executive Director
Comp: $606k
Mr. Paul Leslie Stockdale F.C.A. (Age 49)
M.A., CFO & Executive Director
Comp: $239k
Dr. Alexandre Akoulitchev M.A. (Age 62)
Ma (Oxon), Ph.D., Chief Scientific Officer & Executive Director
Comp: $276k
Mr. Thomas G. Guiel B.A.
Chief Operating Officer
David Blum
Senior Vice President of Marketing
Dr. Steven Arrivo
Senior Vice President of Business & Corporate Development
Dr. Ewan Hunter B.Sc.
Ph.D., Ph.D., (KCL), Chief Data Officer
T. Demain
Company Secretary

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

OBD Stock Analysis - Frequently Asked Questions

How have OBD shares performed in 2024?: Oxford BioDynamics' stock was trading at GBX 28 at the start of the year. Since then, OBD shares have decreased by 68.2% and is now trading at GBX 8.90.
View the best growth stocks for 2024 here.
How were Oxford BioDynamics' earnings last quarter?: Oxford BioDynamics Plc (LON:OBD) posted its earnings results on Tuesday, June, 16th. The biotechnology company reported ($2.20) EPS for the quarter.
What other stocks do shareholders of Oxford BioDynamics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Oxford BioDynamics investors own include Oxford Biomedica (OXB), Frontline (FRO), Fate Therapeutics (FATE), Cargojet (CJT), China Unicom (Hong Kong) (CHU), Casey's General Stores (CASY), Buckle (BKE), Biffa (BIFF), AXT (AXTI) and Grupo Aval Acciones y Valores (AVAL).
How do I buy shares of Oxford BioDynamics?: Shares of OBD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:OBD) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Oxford BioDynamics (OBD) Share Price, News & Analysis

About Oxford BioDynamics Stock (LON:OBD)

OBD Stock Price History

OBD Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

OBD Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info